36E79720R0055_1.docx
DOCX document 15 KB Posted
- Solicitation number
- 36E79720R0055
About this file
This document provides details for a federal pre-solicitation notice for a pharmaceutical contract opportunity. The Department of Veterans Affairs National Acquisition Center intends to issue solicitation number 36E79720R0055 on or around June 17, 2020 to procure once-weekly Glucagon-like peptide-1 receptor agonists for the VA, Bureau of Prisons, and Indian Health Service. Offerors must state the exact brand name and National Drug Code of the drug to be supplied. The contract would have an initial one-year period and four one-year option periods. Interested parties should monitor the Federal Business Opportunities website for solicitation amendments and documents. Questions can be directed to the point of contact, Teresa Hussain, by email. The estimated annual requirements are provided for two formulations each of dulaglutide and semaglutide products.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Contract Opportunity Presolicitation Notice
PRODUCT SERVICE CODE
SUBJECT
CONTRACTING OFFICE'S
ZIP-CODE
SOLICITATION NUMBER
RESPONSE DATE/TIME/ZONE
ARCHIVE
DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
SET-ASIDE
NAICS CODE
CONTRACTING OFFICE
ADDRESS
POINT OF CONTACT
(POC Information Automatically Filled from User Profile Unless Entered)
DESCRIPTION
See Attachment
AGENCY'S URL
URL DESCRIPTION
AGENCY CONTACT'S EMAIL
ADDRESS
EMAIL DESCRIPTION
ADDRESS
POSTAL CODE
COUNTRY
ADDITIONAL INFORMATION
GENERAL INFORMATION
PLACE OF PERFORMANCE
* = Required Field Contract Opportunity Presolicitation Notice GLP1A Glucagon-like Peptide 1 Receptor Agonists 60141 36E79720R0055 06-17-2020 2:30 pm
CENTRAL TIME, CHICAGO, USA
N 325412
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0055 for an unrestrictive procurement for once-weekly Glucagon-like peptide-1 receptor agonists (GLP1 agonist) with an FDA approved indication to reduce risk of major cardiovascular outcomes in adults with type 2 diabetes for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA Pharmaceutical Prime Vendor Program. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79720R0055 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about June 17, 2020, with a tentative closing date of July 2, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Teresa Hussain. Questions can be e-mailed to: Teresa.Hussain@va.gov.
The estimated annual requirements are as follows:
| Item | Description | Size | Estimated Annual Requirements | |
| 1a | ||||
| DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN 4 PACK |
| OR |
| 1 |
| 383,700 |
| 1b |
| SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML 1 PACK |
AND
| 2a |
| DULAGLUTIDE 1.5MG/0.5ML INJ,SOLN,PEN 4 PACK |
| OR |
| 1 |
| 536,592 |
| 2b |
| SEMAGLUTIDE 1MG/0.75ML INJ,SOLN,PEN,1.5ML 2 PACK |
File details come from the government source that posted it. Updated .